NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.2658
+0.0068 (2.63%)
At close: Sep 18, 2026, 4:00 PM EDT
0.2780
+0.0122 (4.59%)
After-hours: Sep 18, 2026, 6:44 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $2.59 million as of September 18, 2026. Its market cap has decreased by -87.15% in one year.
Market Cap
2.59M
Enterprise Value
9.56M
1-Year Change
-87.15%
Ranking
Category
Stock Price
$0.27
ChartMarket Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $2.59M, a decrease of -86.77%. That is a compound annual growth rate of -34.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.59M | -80.24% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daxor | 66.85M |
| Precision Optics Corporation | 48.81M |
| Nephros | 46.81M |
| Harvard Bioscience | 36.19M |
| Milestone Scientific | 36.16M |
| Femasys | 21.69M |
| Retractable Technologies | 21.53M |
| Bionano Genomics | 20.37M |